Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1

Pediatrics. 1997 Oct;100(4):667-70. doi: 10.1542/peds.100.4.667.

Abstract

Objective: To establish the prevalence of endocrinologic disorders in children with neurofibromatosis type 1 (NF1) and the relationship between these disorders and cerebral abnormalities on magnetic resonance imaging.

Design: A prospective follow-up study. Setting. A multidisciplinary neurofibromatosis clinic.

Patients: A total of 122 children diagnosed with NF1 according to diagnostic criteria set by the National Institutes of Health.

Results: Central precocious puberty (CPP) was diagnosed in 3 children and growth hormone deficiency (GHD) in 3 children. Optic pathway gliomas were observed in 15 children; in 9 of the 15 cases, the optic chiasm was involved. Of the 3 children with CPP, only 1 showed a chiasma glioma on magnetic resonance imaging. In 1 case with GHD, an optic chiasm glioma was detected on neuroimaging. Two of the 9 children with an optic chiasm glioma presented with CPP or GHD.

Conclusions: It has been suggested that CPP in children with NF1 is found exclusively in the presence of a chiasma glioma. We conclude that chiasma glioma may not be obligatory in children with NF1 and CPP or GHD. Moreover, we report a prevalence of GHD in children with NF1 of 2.5%, which has not been established earlier.

Publication types

  • Review

MeSH terms

  • Brain / pathology
  • Child
  • Cranial Nerve Neoplasms / diagnosis
  • Cranial Nerve Neoplasms / etiology*
  • Female
  • Follow-Up Studies
  • Glioma / diagnosis
  • Glioma / etiology*
  • Human Growth Hormone / deficiency*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Neurofibromatosis 1 / complications*
  • Neurofibromatosis 1 / pathology
  • Optic Nerve Diseases / diagnosis
  • Optic Nerve Diseases / etiology*
  • Puberty, Precocious / etiology*

Substances

  • Human Growth Hormone